Roswell Park Cancer Institute — Buffalo, New York

Public research footprint of Roswell Park Cancer Institute, compiled from the ClinicalTrials.gov public registry.

1,637

Registered studies

420

Active

173

Recruiting now

917

Completed

250

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Recurrent Platinum-Resistant Fallopian Tube Carcinoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT04646434 — Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing… (Suspended)
NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Roswell Park Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.